Search results for

Alejandro Luna of Olivares & Cía advises Mexico’s R&D pharmaceutical association AMIIF. In July he attended the Trans-Pacific Partnership (TPP) talks in Kota Kinabalu, Malaysia on its behalf. He tells Emma Barraclough about the experience

The Council of the European Union has appointed Théophile Margellos as President of the Boards of Appeal of OHIM. He succeeds Paul Maier, who has moved to head up the new Observatory on IP Enforcement at the Office, and will take up the post in October. Margellos has been chair of the First Board and Third Board, handling trade marks and designs cases respectively, and also coordinated the OHIM mediation team. He has studied in Greece, France and Germany and has previously worked at the Court of Justice of the EU and the European Commission. He has also worked as an IP lawyer and taught law at the University of Picardie Jules Verne in Amiens.

The latest development in the global patent war between Apple and Samsung took another dramatic turn last month. The International Trade Commission (ITC), set to ban imports of Apple's iPhone 4 for infringing Samsung's patents, was overruled by US Trade Representative Michael Froman, citing concerns about the dangers of holders of standards-essential patents (SEPs) gaining undue leverage over the market and the associated public interests.

Declan Hamill, chief of staff and vice president (legal affairs) for Rx&D tells James Nurton why the innovative life sciences industry has concerns about the lack of patent term restoration, utility standards and access to medicines

Cynthia Rowden of Bereskin & Parr explains recent legislation that offers better counterfeiting remedies and streamlines registration procedures

Matthew Zischka and Colin Ingram of Smart & Biggar analyse decisions on computer-implemented inventions, alongside CIPO’s efforts to strengthen and clarify policy

As brand-name producers push for longer data exclusivity and a better appeals process in Canada, Jim Keon, president of the Canadian Generic Pharmaceutical Association, explains the misconceptions about Canadian regulation to Alli Pyrah

The former head of the USPTO says that academic institutions have largely replaced large corporate research centres as a major source of breakthrough innovations, but this raises new challenges to commercialisation

Many readers will be familiar with the curious incident of the dog in the night-time, identified by Sherlock Holmes in Sir Arthur Conan Doyle’s short story “Silver Blaze”. Puzzled, the Scotland Yard detective says: “The dog did nothing in the night-time.” Holmes replies: “That was the curious incident.”

Know your enemy. Did Australian company record company Liberation Music bear this advice in mind when it requested that YouTube block the video of a lecture titled “Open” given by Harvard Law School professor Lawrence Lessig?